Budd‐Chiari syndrome in Sweden: epidemiology, clinical characteristics and survival – an 18‐year experience
- 6 January 2009
- journal article
- Published by Wiley in Liver International
- Vol. 29 (2), 253-259
- https://doi.org/10.1111/j.1478-3231.2008.01838.x
Abstract
The exact incidence and prevalence of Budd-Chiari syndrome (BCS) is unknown in the general population. Published reports differ in terms of the clinical characteristics, effects of therapy and survival. To investigate the epidemiology, clinical presentation and survival in patients with BCS. Retrospective multicentre study in Sweden reviewing the medical records of all patients with BCS 1986-2003, identified from the computerised diagnosis database of 11 hospitals, including all university hospitals and liver transplantation centres. Forty-three patients with BCS were identified, of whom nine (21%) had concomitant portal vein thrombosis. The mean age-standardised incidence and prevalence rates in 1990-2001 were calculated to be 0.8 per million per year and 1.4 per million inhabitants respectively. Myeloproliferative disorders (38%), thrombophilic factors (31%) and oral contraceptives (30%) were common aetiological factors. Two or more risk factors were present in 44%. In 23%, no risk factor was evident. The median follow-up time was 2.7 years. Seventy-two percent were on anticoagulant therapy during follow-up. Transjugular intrahepatic portosystemic shunting, surgical shunting procedures and liver transplantation were performed in 4, 6 and 18 patients respectively. Nineteen patients died. The overall transplantation-free survival at 1, 5 and 10 years was 47, 28 and 17% respectively. Budd-Chiari syndrome is a rare disorder; the mean age-standardised incidence and prevalence rates in Sweden in 1990-2001 were calculated to be 0.8 per million per year and 1.4 per million inhabitants respectively. The presence of a myeloproliferative disorder was a common aetiological factor in our cohort and about half of the patients had a multifactorial aetiology. The transplantation-free survival was poorThis publication has 17 references indexed in Scilit:
- Budd–Chiari syndrome: illustrated review of current managementLiver International, 2008
- Aiming at minimal invasiveness as a therapeutic strategy for Budd-Chiari syndromeHepatology, 2006
- Liver transplantation for Budd–Chiari syndrome: A European study on 248 patients from 51 centresJournal of Hepatology, 2006
- Hepatic venous outflow tract obstruction etiopathogenesis: Asia versus the WestJournal of Gastroenterology and Hepatology, 2004
- Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndromeHepatology, 2004
- Budd–Chiari syndrome: a review by an expert panelJournal of Hepatology, 2003
- Cause of portal or hepatic venous thrombosis in adults: The role of multiple concurrent factorsHepatology, 2000
- Outcome of Budd-Chiari syndrome: A multivariate analysis of factors related to survival including surgical portosystemic shuntingHepatology, 1999
- Prevalence of the factor V Leiden mutation in hepatic and portal vein thrombosis.Gut, 1997
- Epidemiological and clinical features of Budd-Chiari syndrome in JapanJournal of Hepatology, 1995